PMC:7534795 / 4681-4913 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T44","span":{"begin":116,"end":124},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"an, 2020) (Table 1 ).\nTable 1 Overview of some proposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antiox"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T35","span":{"begin":208,"end":217},"obj":"Chemical"},{"id":"T38","span":{"begin":208,"end":215},"obj":"Chemical"}],"attributes":[{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_21241"},{"id":"A36","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_29073"},{"id":"A37","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_38290"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_33229"}],"text":"an, 2020) (Table 1 ).\nTable 1 Overview of some proposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antiox"}

{"project":"LitCovid-sentences","denotations":[{"id":"T25","span":{"begin":22,"end":134},"obj":"Sentence"},{"id":"T26","span":{"begin":135,"end":184},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"an, 2020) (Table 1 ).\nTable 1 Overview of some proposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antiox"}

{"project":"2_test","denotations":[{"id":"33031856-32091533-84038800","span":{"begin":4,"end":8},"obj":"32091533"}],"text":"an, 2020) (Table 1 ).\nTable 1 Overview of some proposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antiox"}

{"project":"LitCovid-PubTator","denotations":[{"id":"181","span":{"begin":208,"end":217},"obj":"Chemical"},{"id":"208","span":{"begin":125,"end":133},"obj":"Species"},{"id":"209","span":{"begin":116,"end":124},"obj":"Disease"}],"attributes":[{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"MESH:D001205"},{"id":"A208","pred":"tao:has_database_id","subj":"208","obj":"Tax:9606"},{"id":"A209","pred":"tao:has_database_id","subj":"209","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"an, 2020) (Table 1 ).\nTable 1 Overview of some proposed pharmacological agents with potential beneficial effects in COVID-19 patients.\nPharmacological intervention Conclusion Reference\nAntioxidants including Vitamin C and E • Antiox"}